CL2008003751A1 -
Compounds derived from benzene substituted with heterocycles; pharmaceutical composition; pharmaceutical kit; and use in the treatment of a parasitic infection in an animal.
- Google Patents
Compounds derived from benzene substituted with heterocycles; pharmaceutical composition; pharmaceutical kit; and use in the treatment of a parasitic infection in an animal.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int BvfiledCriticalIntervet Int Bv
Publication of CL2008003751A1publicationCriticalpatent/CL2008003751A1/en
Compuestos derivados de benceno sustituido con heterociclos; composición farmacéutica; y uso en el tratamiento de una infección parasitaria en un animal.Compounds derived from benzene substituted with heterocycles; pharmaceutical composition; and use in the treatment of a parasitic infection in an animal.
CL2008003751A2007-12-172008-12-16
Compounds derived from benzene substituted with heterocycles; pharmaceutical composition; pharmaceutical kit; and use in the treatment of a parasitic infection in an animal.
CL2008003751A1
(en)
Compounds derived from benzene substituted with heterocycles; pharmaceutical composition; pharmaceutical kit; and use in the treatment of a parasitic infection in an animal.
Compounds derived from heterocycles, gamma secretase modulators; pharmaceutical composition; pharmaceutical kit; and use in the treatment of Alzheimer's.
Compounds derived from chromans and naphthalene substituted with a heterocyclic ring; pharmaceutical composition; and its use in the treatment of acute or chronic nociceptive pain or pain, visceral pain, inflammatory and / or central or peripheral neuropathic pain.
Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.
Compounds derived from substituted fused heterocycles, phosphatidyl-inositol-3 kinase inhibitors; pharmaceutical composition; and use in the treatment of cancer.
Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
Compounds derived from methanopyrazolo [3,4-e] [1,3] diazepine; preparation procedure; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
Nitrogen heterocycle derived compounds, gamma secretase modulators; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases such as Alzheimer's, Down syndrome; pharmaceutical kit.
Compounds derived from 6-phenyl-1h-imidazo [4,5-c] pyridine-4-carbonitrile, inhibitors of cathepsin s and cathepsin k; pharmaceutical composition; and use in the treatment of osteoporosis, atherosclerosis, inflammation, among other diseases.